|
|
再次心脏移植研究概论
|
Abstract:
近年来，越来越多的终末期心脏病患者选择心脏移植手术，随着手术量的逐步增加，越来越多的患者出现了移植术后严重并发症，这时，再次心脏移植(heart retransplantation, RTx)成为了此类患者恢复健康的重要选择。RTx一般因出现移植物功能衰竭、排斥反应、移植物血管病变(cardiac allograft vasculopathy, CAV)或其他严重并发症等，需要再次进行心脏移植手术。虽然RTx可以挽救部分患者的生命，但手术较复杂、预后差，且面临供体分配和伦理争议等挑战。本文描述了TRx的适应症与禁忌症、术后并发症以及相关伦理问题，探讨了相关研究进展。
In recent years, an increasing number of end-stage heart disease patients have chosen heart transplant surgery. With the gradual increase in the number of surgeries, more and more patients have developed severe postoperative complications. In such cases, retransplantation (heart retransplantation, RTx) has become an important option for these patients to recover their health. RTx is generally required when complications such as graft dysfunction, rejection, cardiac allograft vasculopathy (CAV), or other severe complications occur, necessitating another heart transplant surgery. Although RTx can save the lives of some patients, it is a complex procedure with a poor prognosis and faces challenges such as organ allocation and ethical controversies. This article describes the indications and contraindications for RTx, postoperative complications, and related ethical issues, and explores the progress of relevant research.
| [1] | Chambers, D.C., Cherikh, W.S., Goldfarb, S.B., Hayes, D., Kucheryavaya, A.Y., Toll, A.E., et al. (2018) The International Thoracic Organ Transplant Registry of the International Society for Heart and Lung Transplantation: Thirty-Fifth Adult Lung and Heart-Lung Transplant Report—2018; Focus Theme: Multiorgan Transplantation. The Journal of Heart and Lung Transplantation, 37, 1169-1183. https://doi.org/10.1016/j.healun.2018.07.020 |
| [2] | Lund, L.H., Edwards, L.B., Kucheryavaya, A.Y., Benden, C., Christie, J.D., Dipchand, A.I., et al. (2014) The Registry of the International Society for Heart and Lung Transplantation: Thirty-First Official Adult Heart Transplant Report—2014; Focus Theme: Retransplantation. The Journal of Heart and Lung Transplantation, 33, 996-1008. https://doi.org/10.1016/j.healun.2014.08.003 |
| [3] | Belli, E., Leoni Moreno, J.C., Hosenpud, J., Rawal, B. and Landolfo, K. (2014) Preoperative Risk Factors Predict Survival Following Cardiac Retransplantation: Analysis of the United Network for Organ Sharing Database. The Journal of Thoracic and Cardiovascular Surgery, 147, 1972-1977.e1. https://doi.org/10.1016/j.jtcvs.2014.02.013 |
| [4] | Radovancevic, B., McGiffin, D.C., Kobashigawa, J.A., Cintron, G.B., Mullen, G.M., Pitts, D.E., et al. (2003) Retransplantation in 7,290 Primary Transplant Patients: A 10-Year Multi-Institutional Study. The Journal of Heart and Lung Transplantation, 22, 862-868. https://doi.org/10.1016/s1053-2498(02)00803-3 |
| [5] | Srivastava, R., Keck, B.M., Bennett, L.E. and Hosenpud, J.D. (2000) The Results of Cardiac Retransplantation: An Analysis of the Joint International Society for Heart and Lung Transplantation/United Network for Organ Sharing Thoracic Registry. Transplantation, 70, 606-612. https://doi.org/10.1097/00007890-200008270-00013 |
| [6] | Rizvi, S.A., Luc, J.G.Y., Choi, J.H., Phan, K., Moncho Escrivà, E., Patel, S., et al. (2018) Outcomes and Survival Following Heart Retransplantation for Cardiac Allograft Failure: A Systematic Review and Meta-Analysis. Annals of Cardiothoracic Surgery, 7, 12-18. https://doi.org/10.21037/acs.2018.01.09 |
| [7] | Kubiak, G.M., Kwieciński, R., Zakliczyński, M., Hawranek, M., Nożyński, J., Król, B., et al. (2018) Cardiac Retransplantation as a Promising Treatment Option for Late Graft Failure—Zabrze Experience. Kardiologia Polska, 76, 1015-1017. https://doi.org/10.5603/kp.2018.0119 |
| [8] | Klauss, V., König, A., Spes, C., Meiser, B., Rieber, J., Siebert, U., et al. (2000) Cyclosporine versus Tacrolimus (FK 506) for Prevention of Cardiac Allograft Vasculopathy. The American Journal of Cardiology, 85, 266-269. https://doi.org/10.1016/s0002-9149(99)00631-1 |
| [9] | Phan, K., Luc, J.G.Y., Xu, J., Maltais, S., Stulak, J.M., Yan, T.D., et al. (2017) Utilization and Outcomes of Temporary Mechanical Circulatory Support for Graft Dysfunction after Heart Transplantation. ASAIO Journal, 63, 695-703. https://doi.org/10.1097/mat.0000000000000599 |
| [10] | Collins, E.G. and Mozdzierz, G.J. (1993) Cardiac Retransplantation: Determining Limits. Heart Lung, 22, 206-212. |
| [11] | Persad, G., Wertheimer, A. and Emanuel, E.J. (2009) Principles for Allocation of Scarce Medical Interventions. The Lancet, 373, 423-431. https://doi.org/10.1016/s0140-6736(09)60137-9 |
| [12] | (1997) Fair Allocation of Intensive Care Unit Resources. American Thoracic Society. American Journal of Respiratory and Critical Care Medicine, 156, 1282-1301. |
| [13] | Childress, J.F. (2001) Putting Patients First in Organ Allocation: An Ethical Analysis of the U.S. Debate. Cambridge Quarterly of Healthcare Ethics, 10, 365-376. https://doi.org/10.1017/s0963180101004054 |
| [14] | Parfit, D. (1997) Equality and Priority. Ratio, 10, 202-221. https://doi.org/10.1111/1467-9329.00041 |
| [15] | Kumar, R. (1995) Morality, Mortality Vol 1: Death and Whom to Save from It. Journal of Medical Ethics, 21, 248.2-249. https://doi.org/10.1136/jme.21.4.248-a |
| [16] | Howard, D.H. (2001) Hope versus Efficiency in Organ Allocation. Transplantation, 72, 1169-1173. https://doi.org/10.1097/00007890-200109270-00037 |
| [17] | Murphy, T.F. (2004) Gaming the Transplant System. The American Journal of Bioethics, 4, 28. https://doi.org/10.1162/152651604773067532 |
| [18] | Morreim, E.H. (2005) Another Kind of End-Run: Status Upgrades. The American Journal of Bioethics, 5, 11-12. https://doi.org/10.1080/15265160500194246 |
| [19] | Conway, J., Manlhiot, C., Kirk, R., Edwards, L.B., McCrindle, B.W. and Dipchand, A.I. (2014) Mortality and Morbidity after Retransplantation after Primary Heart Transplant in Childhood: An Analysis from the Registry of the International Society for Heart and Lung Transplantation. The Journal of Heart and Lung Transplantation, 33, 241-251. https://doi.org/10.1016/j.healun.2013.11.006 |
| [20] | Bock, M.J., Nguyen, K., Malerba, S., Harrison, K., Bagiella, E., Gelb, B.D., et al. (2015) Pediatric Cardiac Retransplantation: Waitlist Mortality Stratified by Age and Era. The Journal of Heart and Lung Transplantation, 34, 530-537. https://doi.org/10.1016/j.healun.2014.05.014 |
| [21] | Mahle, W.T., Vincent, R.N. and Kanter, K.R. (2005) Cardiac Retransplantation in Childhood: Analysis of Data from the United Network for Organ Sharing. The Journal of Thoracic and Cardiovascular Surgery, 130, 542-546. https://doi.org/10.1016/j.jtcvs.2005.02.050 |
| [22] | Barbieri, L.R., Lourenço-Filho, D.D., Tavares, E.R., Carvalho, P.O., Gutierrez, P.S., Maranhão, R.C., et al. (2017) Influence of Drugs Carried in Lipid Nanoparticles in Coronary Disease of Rabbit Transplanted Heart. The Annals of Thoracic Surgery, 104, 577-583. https://doi.org/10.1016/j.athoracsur.2016.12.044 |
| [23] | 王嘉慧, 孙博, 王丹, 等. MMP-9在心脏移植物血管病变中的作用研究进展[J]. 山东医药, 2016, 56(22): 102-104. |
| [24] | Bartoli, C.R., Kang, J. and Motomura, T. (2020) Decreased RPM Reduces Von Willebrand Factor Degradation with the EVAHEART LVAS: Implications for Device‐specific LVAD Management. Journal of Cardiac Surgery, 35, 1477-1483. https://doi.org/10.1111/jocs.14620 |
| [25] | Zayat, R., Moza, A., Grottke, O., Grzanna, T., Fechter, T., Motomura, T., et al. (2019) In Vitro Comparison of the Hemocompatibility of Two Centrifugal Left Ventricular Assist Devices. The Journal of Thoracic and Cardiovascular Surgery, 157, 591-599.e4. https://doi.org/10.1016/j.jtcvs.2018.07.085 |
